03
Important information regarding the correct use of the
system that does not affect the safety of the patient or the
integrity of the device is displayed over a blue background.
Infection Risk Control on Multi-Patient Tests
• Healthcare professionals must wear gloves during the entire
process of the test.
• A separate lancet or lancing device should be used for each
individual.
• Used Chips, lancets and gloves might be source of infection.
Dispose them in accordance with local regulations to prevent
infections.
• Also, comply with your centre’s internal hygiene and safety
regulations.
There is a potential risk of infection. The healthcare
professionals using the microINR system on several
patients must take into account that all objects that
come into contact with human blood are a possible
source of infection. (See: National Committee for
Clinical Laboratory Standards: Protection of Laboratory
Workers from Instrument Biohazards and Infectious
Disease Transmitted by Blood, Body Fluids and Tissue.
Approved Guideline, NCCLS document M29-A, 1997).
Electromagnetic Compatibility and Electrical Safety
The microINR system complies with electromagnetic
compatibility requirements according to IEC 61326-1 and
61326-2-6 standards.
Do not use the microINR system near sources of
intense electromagnetic radiation, as this could
interfere with its correct operation.
The microINR system complies with electrical safety
requirements according to standards IEC 61010-1 and IEC
61010-2-101.
Do not connect the Meter to computers that do not
comply with standard IEC 60950.
The Meter must be disposed of as indicated in the WEEE
Directive (Waste Electrical and Electronic Equipment
2012/19/UE).
1.3 ORAL ANTICOAGULANT THERAPY
Oral anticoagulant therapy is given to patients to prevent
thromboembolic events such as vein thrombosis, pulmonary
embolism or those linked to atrial fibrillation or replacement of
heart valves.
The treatment entails the need to monitor and adjust the
doses periodically for each patient based on a blood test.
Depending on the cause for oral anticoagulant therapy a
therapeutic range is defined for each patient meaning the
value of the test should lie within that range.
INR and Prothrombin Time
The activity of oral anticoagulants is monitored by measuring
the prothrombin time (PT) in seconds, which is the time it
To Next Page
Loading...
Need help?
General
